A recent bioavailability study raises questions about the universality of the permeability enhancing effect of chitosan on poorly permeable
drugs. Unexpectedly, chitosan reduced the bioavailability of acyclovir. The purpose of this study was to establish a hypothesis that could be tested using a mechanistic oral absorption model to help establish a possible mechanism for this result.
2018 AAPS Annual Meeting PharmSci 360, November 4-7, 2018, Washington, DC
By Michael B Bolger, Mauricio A. García, Peter Langguth